Bazarbachi, A., Boumendil, A., Finel, H., Mohty, M., Castagna, L., Peggs, K., . . . Sureda, A. (2018). Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: A report from the EBMT Lymphoma Working Party.
Citación estilo ChicagoBazarbachi, A., et al. Brentuximab Vedotin Prior to Allogeneic Stem Cell Transplantation in Hodgkin Lymphoma: A Report From the EBMT Lymphoma Working Party. 2018.
Cita MLABazarbachi, A., et al. Brentuximab Vedotin Prior to Allogeneic Stem Cell Transplantation in Hodgkin Lymphoma: A Report From the EBMT Lymphoma Working Party. 2018.
Precaución: Estas citas no son 100% exactas.